Company profile

Syros Pharmaceuticals, Inc. Insider Trading

SYRS

Every SEC Form 4 insider trading filing for Syros Pharmaceuticals, Inc. (SYRS) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Sector
Pharmaceutical Preparations
CIK
0001556263
Filings
70
Insiders
16
Last filing
2024-12-02

Activity summary

No insider transactions in the last 30 days. The most recent was on December 2, 2024, when Simonian Nancy A sold 37,070 shares. 70 filings from 16 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q3 22 to Q4 24. Syros Pharmaceuticals, Inc. insiders are net buyers across the period shown.

Q3 22Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $4.0M.

No insider activity recorded for SYRS in the last 90 days.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Dec 2, 2024Simonian Nancy ASYRS
Sale
37,070$0.27$10K
Nov 25, 2024Simonian Nancy ASYRS
Sale
134,713$0.27$36K
Nov 19, 2024Quirk Gerald ESYRS
Sale
46,657$0.22$10K
Nov 18, 2024Haas JasonSYRS
Sale
137,803$0.21$29K
Nov 18, 2024Roth DavidSYRS
Sale
12,099$0.20$2K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=SYRS" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Chee ConleyChief Commercial Officer4 filings+$116K
Haas JasonChief Financial Officer5 filings+$121K
Young Richard ADirector1 filing$178K
Simonian Nancy APresident & CEO2 filings$46K
Stephens KristinChief Development Officer2 filings$21K